MDxHealth (MDXH) Interest Expenses (2021 - 2026)

MDxHealth has disclosed Interest Expenses across 6 years of filings, most recently posting -$8.9 million for Q1 2026.

• Interest Expenses for Q1 2026 came in at -$8.9 million, down 72.89% year-over-year; the trailing twelve-month figure through Mar 2026 was -$14.2 million (down 20.92% YoY), and the FY2025 annual result was $23.0 million, up 50.31% from the prior year.
• Interest Expenses came in at -$8.9 million for Q1 2026 at MDxHealth, down from -$5.2 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of -$11599.0 in Q2 2025 to a low of -$8.9 million in Q1 2026.
• The 5-year median for Interest Expenses is -$3.3 million (2022), against an average of -$3.6 million.
• Across the five-year window, Interest Expenses plunged 615.79% in 2023 and surged 99.74% in 2025, its largest moves.
• MDxHealth's Interest Expenses stood at -$3.4 million in 2022, then plunged by 31.22% to -$4.4 million in 2023, then jumped by 50.49% to -$2.2 million in 2024, then sank by 139.73% to -$5.2 million in 2025, then slumped by 70.85% to -$8.9 million in 2026.
• The last three Interest Expenses figures came in at -$8.9 million (Q1 2026), -$5.2 million (Q4 2025), and -$11599.0 (Q2 2025), per Business Quant data.